We already knew they are working on that with Christina Sanchez. That's her speciality.
Nothing new for the market to price in.
I say we'll head down to the gap at 4.5 and then head back up.
Good company though. Good management, but timing wise, the market may put chips somewhere else until the research/ announcement give us real NEW NEWS.
Ann: Novel Cannabis Pathway for Treatment of Breast Cancer, page-9
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
